Michael Lisjak

Michael Lisjak

General Counsel at CYCLO THERAPEUTICS, INC.

Net worth: 15 872 $ as of 2024-05-30

50 year
Health Technology
Consumer Services

Network origin in Michael Lisjak first degree

EntityEntity typeIndustry
Public Company Biotechnology 15
Sanofi SA
2
Extinct Pharmaceuticals: Major 2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Michael Lisjak via their personal network

CompanySectorRelated peopleMain position
Medical Specialties

F. Ostronic

Director/Board Member

IMMUNOMEDICS, INC. Biotechnology

William Conkling

Sales & Marketing

GT BIOPHARMA, INC. Pharmaceuticals: Major

Shawn Cross

Chief Executive Officer

PFIZER, INC. Pharmaceuticals: Major

Alexandra Kropotova

Director/Board Member

FORWARD INDUSTRIES, INC. Other Consumer Specialties

Scott Fine

Sharon Hrynkow

Director/Board Member

Director/Board Member

Beverages: Alcoholic

Scott Fine

William Shanahan

Markus Walter Sieger

Director/Board Member

Director/Board Member

Director/Board Member

Investment Banks/Brokers

Shawn Cross

Analyst-Equity

Miscellaneous Commercial Services

William Conkling

Director/Board Member

Investment Banks/Brokers

Shawn Cross

Corporate Officer/Principal

College of the Holy Cross (Massachusetts) College/University

F. Ostronic

Undergraduate Degree

University of California, Los Angeles College/University

Shawn Cross

Undergraduate Degree

College/University

William Conkling

Undergraduate Degree

Old Dominion University College/University

F. Ostronic

Graduate Degree

State University of New York at Buffalo College/University

Russ Belden

Undergraduate Degree

College/University

Jeffrey Tate

Doctorate Degree

General Government

Sharon Hrynkow

Corporate Officer/Principal

Investment Trusts/Mutual Funds

Sharon Hrynkow

Corporate Officer/Principal

University of Copenhagen College/University

Lise Lund Kjems

Doctorate Degree

Miscellaneous Commercial Services

Sharon Hrynkow

Corporate Officer/Principal

College/University

Shawn Cross

Corporate Officer/Principal

IBIO, INC. Pharmaceuticals: Other

Alexandra Kropotova

Director/Board Member

Internet Software/Services

Sharon Hrynkow

Director/Board Member

Investment Managers

Shawn Cross

Corporate Officer/Principal

Investment Managers

Russ Belden

Corporate Officer/Principal

Miscellaneous Commercial Services

Sharon Hrynkow

Corporate Officer/Principal

Chemicals: Specialty

Jeffrey Tate

Chief Executive Officer

Pharmaceuticals: Major

Jeffrey Tate

Chief Tech/Sci/R&D Officer

Ferrazo Environmental Technologies, Inc.

Jeffrey Tate

Chief Executive Officer

J Jireh Products, Inc.

Jeffrey Tate

President

Sphingo Biotech, Inc.

Jeffrey Tate

Chief Executive Officer

J. Benson Tate Consultants LLC

Jeffrey Tate

Corporate Officer/Principal

Miscellaneous Commercial Services

Scott Fine

Sharon Hrynkow

Director/Board Member

President

Columbia Business School College/University

Shawn Cross

Masters Business Admin

EDITAS MEDICINE, INC. Biotechnology

Gerald F. Cox

Chief Tech/Sci/R&D Officer

The Leonard N Stern School of Business College/University

William Conkling

Masters Business Admin

The University of Maryland Francis King Carey School of Law College/University

F. Ostronic

Graduate Degree

Harvard College College/University

Gerald F. Cox

Undergraduate Degree

BIOPLUS ACQUISITION CORP. Financial Conglomerates

Shawn Cross

Director/Board Member

APPLIED MOLECULAR TRANSPORT INC. Biotechnology

Shawn Cross

Chief Executive Officer

RAFAEL HOLDINGS, INC. Real Estate Development

William Conkling

Chief Executive Officer

SAB BIOTHERAPEUTICS, INC. Biotechnology

Alexandra Kropotova

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Ai Min Hui

Director/Board Member

Statistics

International

United States 40
United Kingdom 3
Denmark 2
China 2

Sectoral

Consumer Services 13
Health Technology 11
Finance 8
Commercial Services 5
Consumer Durables 2

Operational

Director/Board Member 60
Corporate Officer/Principal 39
Independent Dir/Board Member 18
Undergraduate Degree 13
Chief Executive Officer 12